Skip to main content

Biomax Informatics Raises EUR2.25M in VC Funding

This article has been updated from an  earlier version to reflect that Biomax Solutions is independent of Biomax Informatics.

 

NEW YORK, Oct. 13 (GenomeWeb News) - Biomax Informatics has raised €2.25 million ($2.75 million) in venture capital funding, the Munich-based company said yesterday.

 

Investors included BayBG Bayerische Beteiligungsgesellschaft, Ecos Venture Capital Beteiligungs AG, and S-UBG Bayern Gesellschaft  f r  Unternehmensbeteiligungen. There was no lead investor, according to Biomax CFO Hein Osenberg.

 

Biomax plans to use the funding to develop new products and to expand its business in the US. Osenberg told GenomeWeb News that the company wants to expand its marketing and sales activies in the US, working together with its independent US partner, Biomax Solutions, which is based in Falmouth, Mass.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.